Opinions on Pneumocystis jirovecii prophylaxis in autoimmune neuromuscular disorders

Area of Science:

• Infectious Diseases
• Immunology
• Pulmonology

Background:

• Pneumocystis jirovecii (PJ) causes opportunistic infections, particularly interstitial pneumonia in immunocompromised individuals.
• Prophylaxis against PJ is often recommended for patients with autoimmune neuromuscular conditions on immunosuppressive therapy.

Purpose of the Study:

• To evaluate the necessity of routine Pneumocystis jirovecii prophylaxis in patients with autoimmune neuromuscular diseases.
• To identify specific risk factors that may warrant PJ prophylaxis in this patient group.

Main Methods:

• Review of available data on Pneumocystis jirovecii infection rates in patients with autoimmune neuromuscular diseases.
• Analysis of comorbidities and clinical factors associated with increased PJ infection risk.

Main Results:

• The risk of Pneumocystis jirovecii infection in patients with autoimmune neuromuscular diseases is generally very low.
• Comorbidities such as interstitial lung disease, lymphopenia, low CD4 counts, organ failure, and active cancer increase PJ infection risk.

Conclusions:

• Widespread, routine prophylaxis against Pneumocystis jirovecii is likely unnecessary for most patients with autoimmune neuromuscular conditions.
• Prophylaxis decisions should be individualized based on the presence of specific risk factors and comorbidities.